Abstract 364P
Background
To develop artificial intelligence auto-segmentation model that generates consistent, high-quality lymph nodes contouring in head and neck cancer patients who received radiotherapy.
Methods
There were 60 computed tomography (CT) scans were retrospectively selected into training and another 60 CT scans were collected into cross-validation. All target delineations covered head and neck lymph node level I through V and based on the Radiation Therapy Oncology Group (RTOG) guideline. All targets were approved by radiation oncologists specializing in head and neck cancer. The volume of interest and all approved contours were used to train a 3D U-Net model. Different lymph node levels were trained independently. The trained model was used on cross-validation group. Auto-segmentations were revised by 2 radiation oncologists.
Results
The Dice Similarity Coefficients were 0.79 and 0.88 in trained group and cross-validation group. The volume changes ranged from -22.2 to 89.0 cm3. The center shift for x-direction, y-direction, and z-direction were -0.57 to 0.16 cm, -0.14 to 0.88 cm, and -0.19 to 0.38 cm, respectively.
Conclusions
We developed an artificial intelligence auto-segmentation model to autodelineate head and neck lymph nodes. Most results of auto-segmentations were acceptable after radiation oncologist review. This enables more efficient and consistent targeting of neck lymph nodes in radiation treatment planning.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
26P - Subcutaneous trastuzumab versus intravenous trastuzumab for treatment of patients with HER2-positive breast cancer: A time, motion and cost-benefit assessment in a day care oncology unit in China
Presenter: Bei Sun
Session: Poster Display
Resources:
Abstract
27P - The biological characteristics of HER2-low in TNBC using mRNA profiling and molecular subtypes
Presenter: Asako Tsuruga
Session: Poster Display
Resources:
Abstract
28P - One-week ultra-hypofractionated partial breast RT in early breast cancer: 3DCRT vs IMRT
Presenter: Nurilla Zaynutdinov
Session: Poster Display
Resources:
Abstract
30P - Stereotactic body radiotherapy using cyberknife versus interstitial brachytherapy in accelerated partial breast irradiation on left-sided breast: A comparison of preliminary clinical result and dosimetric characteristics
Presenter: Ting-Na Wei
Session: Poster Display
Resources:
Abstract
31P - Prognostic implication of breast edema on preoperative breast MRI in breast cancer
Presenter: Ki-tae Hwang
Session: Poster Display
Resources:
Abstract
32P - Efficacy of olanzapine in the prophylaxis of delayed chemotherapy-induced nausea and vomiting in breast cancer patients receiving dose-dense AC with a steroid-sparing regimen: A single-center pilot study
Presenter: Manami Tada
Session: Poster Display
Resources:
Abstract
34P - Social support as the mediator of the association between unmet needs and happiness among women with early breast cancer
Presenter: Nithiya Sinarajoo
Session: Poster Display
Resources:
Abstract
35P - Prospective study assessing the efficacy and safety of a scalp cooling device for the prevention of alopecia in breast cancer patients undergoing (neo)adjuvant chemotherapy
Presenter: Winnie Yeo
Session: Poster Display
Resources:
Abstract
37P - To excise or not to excise: Preventive management of early breast cancer in atypical ductal hyperplasia patients
Presenter: Clarisse Hing
Session: Poster Display
Resources:
Abstract
38P - Exploring prognostic factors in patients achieving PCR after neoadjuvant therapy for triple-negative breast cancer: A retrospective study based on SEER data
Presenter: Lv Wenjie
Session: Poster Display
Resources:
Abstract